Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Ljunggren

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of Medicinal Chemistry|March 1, 1975
Fibrin-stabilizing factor inhibitors. 12. 5-Dibenzylaminopentylamine and related compounds, a new type of FSF inhibitorsK J Hoffmann, P Stenberg, C Ljunggren, et al.
Acta Pharmaceutica Suecica|January 1, 1979
Acetylene compounds of potential pharmacological value. XXVIII. Oxotremorine analogues substituted with a methyl group in the lactam ringB Ringdahl, Z Muhi-Eldeen, C Ljunggren, et al.
Developments in Biological Standardization|January 1, 1975
Hepatitis B immune serum globulin in prevention of hepatitis B among hospital personnel. Preliminary report from a controlled trialS Iwarson, J Ahlmén, E Eriksson, et al.
The American Journal of the Medical Sciences|September 1, 1975
Hepatitis B immune serum globulin and standard gamma globulin in prevention of hepatitis B infection among hospital staff: a preliminary reportS Iwarson, H Kjellman, J Ahlmén, et al.
The Journal of Infectious Diseases|March 1, 1977
Hepatitis B immune globulin in prevention of hepatitis B among hospital staff membersS Iwarson, J Ahlmén, E Eriksson, et al.
Journal of Medicinal Chemistry|June 1, 1974
Fibrin-stabilizing factor inhibitors. 11. Monodansylated weak aliphatic diaminesC Ljunggren, K J Hoffmann, P Stenberg, et al.
Annals of the New York Academy of Sciences|December 8, 1972
Fibrin-stabilizing factor inhibitorsJ L Nilsson, P Stenberg, C Ljunggren, et al.
Acta Pharmaceutica Suecica|June 1, 1973
Fibrin-stabilizing factor inhibitors. 8. Pyridine derivatives as charge-transfer complex acceptorsJ L Nilsson, K J Hoffmann, C Ljunggren, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Medicinal Chemistry|March 1, 1975
Fibrin-stabilizing factor inhibitors. 12. 5-Dibenzylaminopentylamine and related compounds, a new type of FSF inhibitorsK J Hoffmann, P Stenberg, C Ljunggren, et al.
Acta Pharmaceutica Suecica|January 1, 1979
Acetylene compounds of potential pharmacological value. XXVIII. Oxotremorine analogues substituted with a methyl group in the lactam ringB Ringdahl, Z Muhi-Eldeen, C Ljunggren, et al.
Developments in Biological Standardization|January 1, 1975
Hepatitis B immune serum globulin in prevention of hepatitis B among hospital personnel. Preliminary report from a controlled trialS Iwarson, J Ahlmén, E Eriksson, et al.
The American Journal of the Medical Sciences|September 1, 1975
Hepatitis B immune serum globulin and standard gamma globulin in prevention of hepatitis B infection among hospital staff: a preliminary reportS Iwarson, H Kjellman, J Ahlmén, et al.
The Journal of Infectious Diseases|March 1, 1977
Hepatitis B immune globulin in prevention of hepatitis B among hospital staff membersS Iwarson, J Ahlmén, E Eriksson, et al.
Journal of Medicinal Chemistry|June 1, 1974
Fibrin-stabilizing factor inhibitors. 11. Monodansylated weak aliphatic diaminesC Ljunggren, K J Hoffmann, P Stenberg, et al.
Annals of the New York Academy of Sciences|December 8, 1972
Fibrin-stabilizing factor inhibitorsJ L Nilsson, P Stenberg, C Ljunggren, et al.
Acta Pharmaceutica Suecica|June 1, 1973
Fibrin-stabilizing factor inhibitors. 8. Pyridine derivatives as charge-transfer complex acceptorsJ L Nilsson, K J Hoffmann, C Ljunggren, et al.
Pageof 2